Interestingly, the benefit of LCZ696 treatment which reduces significantly the mortality of patients with chronic heart failure seems also to be associated with increased heart vascularisation, as a result of increased endothelial and WT1+ cell proliferation. The gene discussed is WT1; the disease is congestive heart failure.